Although, no differences between individual transductants with silenced expression of TGF-β1 were observed, the obtained data showed that only the cells with reduced ability to produce TGF-β1 effectively differentiated immature dendritic cells into their mature stage, giving them the opportunity for potent presentation of tumor antigens. The gene discussed is TGFB1; the disease is neoplasm.